Cognitive dysfunction in cancer patients: An educational needs area improved by a single intervention

Journal of Cancer Education

Volumn 22, Issue 3, 2007, Pages 197-201

  Vetto, Irene Perez ^a   Vetto, John T ^b,c  

^a ONCOLOGY NURSING SOCIETY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AWARENESS; BEHAVIOR THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; COGNITIVE DEFECT; EDUCATION; HEALTH SURVEY; HUMAN; MORBIDITY; ONCOLOGY NURSING; PATIENT EDUCATION; PATIENT INFORMATION; PRETEST POSTTEST CONTROL GROUP DESIGN; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROGRAM DEVELOPMENT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SKILL; STATISTICAL SIGNIFICANCE;

EID: 35348907425     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03174337     Document Type: Article

References (15)

1. Kayl AE, Myers CA. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol. 2006;18:24-28.
2. Staat K, Sagatore M. The phenomenon of chemo brain. Clin J Oncol Nurs. 2005;9:713-721.
3. O'Shaughnessy J. Chemotherapy-related cognitive dysfunction in breast cancer. Semin Oncol Nurs. 2003;19(suppl 2):17-24.
4. Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard dose chemotherapy in women with breast carcinoma: results of a prospective, randomized longitudinal trial. Cancer. 2004;100:2292-2299.
5. Castellon SA, Ganz PA, Bower JE, et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26:955-969.
6. Rose GM, Hopper A, DeVivo M, Tehim A. Phosphodiesterase inhibitors for cognitive enhancement. Curr Pharm Des. 2005;11:3329-3334.
7. Cunningham RS. Anemia in the oncology patient: cognitive function and cancer. Cancer Nurs. 2003;26(suppl):38S-42S.
8. Troen A, Rosenberg I. Homocysteine and cognitive function. Semin Vasc Med. 2005;5:209-214.
9. O'Shaughnessy JA. Chemotherapy-induced cognitive dysfunction: a clearer picture. Clin Breast Cancer. 2003;4(suppl 2):S89-S94.
10. Krueukles BP, Schagen SB, Riddenerinkhof KR, et al. Electrophysiological correlates of information processing in breast cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat. 2005;94:53-61
11. Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry. 2003;8:201-216.
12. Downie FP, Mar Fan HG, Youde-Tchen N, et al. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology. 2006;15:921-930.
13. Mar Fan HG, Houede-Tchen N, Yi Q-L, et al. Fatigues, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005;23:8025-8032.
14. Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104:788-793.
15. Brown, JD. Using Surveys in Language Programs. Cambridge, England: Cambridge University Press; 2000.